[1]	Robey RW, Pluchino KM, Hall MD, et al. Revisiting the role of ABC transporters in multidrug-resistant cancer[J]. Nat Rev Cancer, 2018, 18(7):452-464.DOI:10.1038/s41568-018-0005-8. Cited in this article [1]

[2]	Wu CP, Hsiao SH, Wu YS. Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2[J]. Drug Resist Updat, 2023,71:101011.DOI:10.1016/j.drup.2023.101011. Cited in this article [1]

[3]	Gil-Martins E, Barbosa DJ, Silva V, et al. Dysfunction of ABC transporters at the blood-brain barrier:role in neurological disorders[J]. Pharmacol Ther, 2020,213:107554.DOI:10.1016/j.pharmthera.2020.107554. Cited in this article [1]

[4]	Schulz JA, Hartz AMS, Bauer B. ABCB1 and ABCG2 regulation at the blood-brain barrier:potential new targets to improve brain drug delivery[J]. Pharmacol Rev, 2023, 75(5):815-853.DOI:10.1124/pharmrev.120.000025. Cited in this article [2]

[5]	Sajid A, Rahman H, Ambudkar SV. Advances in the structure,mechanism and targeting of chemoresistance-linked ABC transporters[J]. Nat Rev Cancer, 2023, 23(11):762-779.DOI:10.1038/s41568-023-00612-3. Cited in this article [1]

[6]	Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro:cross-resistance,radioautographic,and cytogenetic studies[J]. Cancer Res, 1970, 30(4):1174-1184. Cited in this article [1]

[7]	Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants[J]. Biochim Biophys Acta, 1976, 455(1):152-162.DOI:10.1016/0005-2736(76)90160-7. Cited in this article [1]

[8]	Kim Y, Chen J. Molecular structure of human P-glycoprotein in the ATP-bound,outward-facing conformation[J]. Science, 2018, 359(6378):915-919.DOI:10.1126/science.aar7389. Cited in this article [1]

[9]	Alam A, Kowal J, Broude E, et al. Structural insight into substrate and inhibitor discrimination by human P-glycoprotein[J]. Science, 2019, 363(6428):753-756.DOI:10.1126/science.aav7102. Cited in this article [2]

[10]	Ahmed Juvale II, Abdul Hamid AA, Abd Halim KB, et al. P-glycoprotein:new insights into structure,physiological function,regulation and alterations in disease[J]. Heliyon, 2022, 8(6):e09777.DOI:10.1016/j.heliyon.2022.e09777. Cited in this article [1]

[11]	Seelig A, Li-Blatter X. P-glycoprotein(ABCB1)-weak dipolar interactions provide the key to understanding allocrite recognition,binding,and transport[J]. Cancer Drug Resist, 2023, 6(1):1-29.DOI:10.20517/cdr.2022.59. Cited in this article [1]

[12]	Alam A, Locher KP. Structure and mechanism of human ABC transporters[J]. Annu Rev Biophys, 2023,52:275-300.DOI:10.1146/annurev-biophys-111622-091232. Cited in this article [1]

[13]	张小莉, 毛鑫羽, 李自强, 等. 肺细胞药物转运体研究进展[J]. 中国新药杂志, 2021, 30(8):705-711.DOI:10.3969/j.issn.1003-3734.2021.08.006. Cited in this article [1]

[14]	芮萌, 李龙芸, 刘丽华. Pgp、MRP和p53蛋白在肺癌组织中的表达及其意义[J]. 中华内科杂志, 2000, 39(3):194.DOI:10.3760/j.issn:0578-1426.2000.03.021. Cited in this article [1]

[15]	Takano M, Higa S, Furuichi Y, et al. Suppression of P-glycoprotein by cigarette smoke extract in human lung-derived A549/P-gp cells[J]. Drug Metab Pharmacokinet, 2020, 35(2):214-219.DOI:10.1016/j.dmpk.2019.12.001. Cited in this article [1]

[16]	Mahmoud N, Hegazy MF, Wadie W, et al. Naphthoquinone derivatives as P-glycoprotein inducers in inflammatory bowel disease:2D monolayers,3D spheroids,and in vivo models[J]. Pharmacol Res, 2022,179:106233.DOI:10.1016/j.phrs.2022.106233. Cited in this article [1]

[17]	Mai Y, Dou L, Yao Z, et al. Quantification of P-glycoprotein in the gastrointestinal tract of humans and rodents:methodology,gut region,sex,and species matter[J]. Mol Pharm, 2021, 18(5):1895-1904.DOI:10.1021/acs.molpharmaceut.0c00574. Cited in this article [1]

[18]	聂昊, 王晖. P糖蛋白在不同组织中的分布与功能研究进展[J]. 广东药学院学报, 2012, 28(4):456-460.DOI:10.3969/j.issn.1006-8783.2012.04.026. Cited in this article [1]

[19]	Zhang YJ, Xu JJ, Wang P, et al. Multidrug resistance gene and its relationship to ulcerative colitis and immune status of ulcerative colitis[J]. Genet Mol Res, 2014, 13(4):10837-10851.DOI:10.4238/2014.December.19.5. Cited in this article [1]

[20]	丛熙, 樊建慧. P-糖蛋白对结肠癌多药耐药的影响[J]. 中国生物化学与分子生物学报, 2019, 35(1):19-26.DOI:10.13865/j.cnki.cjbmb.2019.01.04. Cited in this article [1]

[21]	Guo M, Bughio S, Sun Y, et al. Age-related P-glycoprotein expression in the intestine and affecting the pharmacokinetics of orally administered enrofloxacin in broilers[J]. PLoS One, 2013, 8(9):e74150.DOI:10.1371/journal.pone.0074150. Cited in this article [1]

[22]	Warrington JS, Greenblatt DJ, von Moltke LL. The effect of age on P-glycoprotein expression and function in the Fischer-344 rat[J]. J Pharmacol Exp Ther, 2004, 309(2):730-736.DOI:10.1124/jpet.103.061234. Cited in this article [2]

[23]	Thorgeirsson SS, Silverman JA, Gant TW, et al. Multidrug resistance gene family and chemical carcinogens[J]. Pharmacol Ther, 1991, 49(3):283-292.DOI:10.1016/0163-7258(91)90059-u. Cited in this article [1]

[24]	Pilotto Heming C, Muriithi W, Wanjiku Macharia L, et al. P-glycoprotein and cancer:what do we currently know[J]. Heliyon, 2022, 8(10):e11171.DOI:10.1016/j.heliyon.2022.e11171. Cited in this article [1]

[25]	Ma QJ, Zhang YC, Shi JS, et al. Clinical significance of P-glycoprotein and glutathione S-transferase π expression in gallbladder carcinoma[J]. Exp Ther Med, 2014, 7(3):635-639.DOI:10.3892/etm.2014.1472. Cited in this article [1]

[26]	Patel D, Sethi N, Patel P, et al. Exploring the potential of P-glycoprotein inhibitors in the targeted delivery of anti-cancer drugs:a comprehensive review[J]. Eur J Pharm Biopharm, 2024,198:114267.DOI:10.1016/j.ejpb.2024.114267. Cited in this article [1]

[27]	Henrique R, Oliveira AI, Costa VL, et al. Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer[J]. BMC Genomics, 2013, 14:898.DOI:10.1186/1471-2164-14-898. Cited in this article [1]

[28]	Demidenko R, Razanauskas D, Daniunaite K, et al. Frequent down-regulation of ABC transporter genes in prostate cancer[J]. BMC Cancer, 2015, 15:683.DOI:10.1186/s12885-015-1689-8. Cited in this article [1]

[29]

Huang B, Fu SJ, Fan WZ, et al. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt,MAPK/ERK signaling in renal cell carcinoma cell line 769P[J]. Cancer Lett, 2016, 376(1):148-154.DOI:10.1016/j.canlet.2016.03.041. Cited in this article [1]

[30]	Guan Y, Lei H, Xing C, et al. Multimodal nanoplatform with ROS amplification to overcome multidrug resistance in prostate cancer via targeting P-glycoprotein and ferroptosis[J]. Adv Healthc Mater, 2024, 13(3):e2301345.DOI:10.1002/adhm.202301345. Cited in this article [1]

[31]	Montanari F, Ecker GF. Prediction of drug-ABC-transporter interaction-recent advances and future challenges[J]. Adv Drug Deliv Rev, 2015, 86:17-26.DOI:10.1016/j.addr.2015.03.001. Cited in this article [1]

[32]	Cordon-Cardo C, O’Brien JP, Casals D, et al. Multidrug-resistance gene(P-glycoprotein)is expressed by endothelial cells at blood-brain barrier sites[J]. Proc Natl Acad Sci U S A, 1989, 86(2):695-698.DOI:10.1073/pnas.86.2.695. Cited in this article [1]

[33]	Uchida Y, Zhang Z, Tachikawa M, et al. Quantitative targeted absolute proteomics of rat blood-cerebrospinal fluid barrier transporters:comparison with a human specimen[J]. J Neurochem, 2015, 134(6):1104-1115.DOI:10.1111/jnc.13147. Cited in this article [1]

[34]	Campos CR, Schroter C, Wang X, et al. ABC transporter function and regulation at the blood-spinal cord barrier[J]. J Cereb Blood Flow Metab, 2012, 32(8):1559-1566.DOI:10.1038/jcbfm.2012.47. Cited in this article [1]

[35]	Chai AB, Callaghan R, Gelissen IC. Regulation of P-glycoprotein in the brain[J]. Int J Mol Sci, 2022, 23(23):14667.DOI:10.3390/ijms232314667. Cited in this article [1]

[36]	Nance E, Pun SH, Saigal R, et al. Drug delivery to the central nervous system[J]. Nat Rev Mater, 2022, 7(4):314-331.DOI:10.1038/s41578-021-00394-w. Cited in this article [1]

[37]	Meng Z, Liu Y, Zhou J, et al. Drug transport across the blood-testis barrier[J]. Am J Transl Res, 2022, 14(9):6412-6423. Cited in this article [1]

[38]	Hau RK, Wright SH, Cherrington NJ. In vitro and in vivo models for drug transport across the blood-testis barrier[J]. Drug Metab Dispos, 2023, 51(9):1157-1168.DOI:10.1124/dmd.123.001288. Cited in this article [1]

[39]	Wanjari UR, Gopalakrishnan AV. Blood-testis barrier:a review on regulators in maintaining cell junction integrity between Sertoli cells[J]. Cell Tissue Res, 2024, 396(2):157-175.DOI:10.1007/s00441-024-03894-7. Cited in this article [1]

[40]	Soo PS, Hiscock J, Botting KJ, et al. Maternal undernutrition reduces P-glycoprotein in guinea pig placenta and developing brain in late gestation[J]. Reprod Toxicol, 2012, 33(3):374-381.DOI:10.1016/j.reprotox.2012.01.013. Cited in this article [1]

[41]	Huang QT, Shynlova O, Kibschull M, et al. P-glycoprotein expression and localization in the rat uterus throughout gestation and labor[J]. Reproduction, 2016, 152(3):195-204.DOI:10.1530/REP-16-0161. Cited in this article [2]

[42]	Elmeliegy M, Vourvahis M, Guo C, et al. Effect of P-glycoprotein(P-gp)inducers on exposure of P-gp substrates:review of clinical drug-drug interaction studies[J]. Clin Pharmacokinet, 2020, 59(6):699-714.DOI:10.1007/s40262-020-00867-1. Cited in this article [1]

[43]	余露婷, 周瑾, 刘福林, 等. 孕期不良环境所致胎盘糖皮质激素屏障改变机制的研究进展[J]. 中国生育健康杂志, 2018, 29(5):476-479.DOI:10.3969/j.issn.1671-878X.2018.05.022. Cited in this article [2]

[44]	白梦如, 孙冬黎, 蒋惠娣, 等. 胎盘中转运体的功能性表达与调控[J]. 药学学报, 2016, 51(6):879-885.DOI:10.16438/j.0513-4870.2015-0861. Cited in this article [1]

[45]

Biali ME, Auvity S, Cisternino S, et al. Dissimilar effect of P-glycoprotein and breast cancer resistance protein inhibition on the distribution of erlotinib to the retina and brain in humans and mice[J]. Mol Pharm, 2023, 20(11):5877-5887.DOI:10.1021/acs.molpharmaceut.3c00715. Cited in this article [1]

[46]	Pascual-Pasto G, Olaciregui NG, Opezzo JAW, et al. Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier[J]. J Control Release, 2017, 264:34-44.DOI:10.1016/j.jconrel.2017.08.018. Cited in this article [1]

[47]

Zhang Z, Uchida Y, Hirano S, et al. Inner blood-retinal barrier dominantly expresses breast cancer resistance protein:comparative quantitative targeted absolute proteomics study of CNS barriers in pig[J]. Mol Pharm, 2017, 14(11):3729-3738.DOI:10.1021/acs.molpharmaceut.7b00493. Cited in this article [1]

[48]	Somisetty S, Santina A, Sarraf D, et al. The impact of systemic medications on retinal function[J]. Asia Pac J Ophthalmol(Phila), 2023, 12(2):115-157.DOI:10.1097/APO.0000000000000605. Cited in this article [1]

[49]	Hashimoto N, Nakamichi N, Yamazaki E, et al. P-glycoprotein in skin contributes to transdermal absorption of topical corticosteroids[J]. Int J Pharm, 2017, 521(1-2):365-373.DOI:10.1016/j.ijpharm.2017.02.064. Cited in this article [1]

[50]	Hashimoto N, Nakamichi N, Uwafuji S, et al. ATP binding cassette transporters in two distinct compartments of the skin contribute to transdermal absorption of a typical substrate[J]. J Control Release, 2013, 165(1):54-61.DOI:10.1016/j.jconrel.2012.10.011. Cited in this article [1]

[51]	Skazik C, Wenzel J, Marquardt Y, et al. P-glycoprotein(ABCB1) expression in human skin is mainly restricted to dermal components[J]. Exp Dermatol, 2011, 20(5):450-452.DOI:10.1111/j.1600-0625.2010.01237.x. Cited in this article [1]

[52]	单葵, 李桂明. Bowen病、皮肤鳞状细胞癌、Paget病中P糖蛋白的表达及意义[J]. 中华皮肤科杂志, 2001, 34(4):293.DOI:10.3760/j.issn:0412-4030.2001.04.020. Cited in this article [1]

[53]	Gegotek A, Skrzydlewska E. The role of ABC transporters in skin cells exposed to UV radiation[J]. Int J Mol Sci, 2022, 24(1):115.DOI:10.3390/ijms24010115. Cited in this article [1]

[54]	de Jonge-Peeters SD, Kuipers F, de Vries EG, et al. ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance[J]. Crit Rev Oncol Hematol, 2007, 62(3):214-226.DOI:10.1016/j.critrevonc.2007.02.003. Cited in this article [1]

[55]

Ahrweiler-Sawaryn MC, Biswas A, Frias C, et al. Novel gold(I)complexes induce apoptosis in leukemia cells via the ROS-induced mitochondrial pathway with an upregulation of Harakiri and overcome multi drug resistances in leukemia and lymphoma cells and sensitize drug resistant tumor cells to apoptosis in vitro[J]. Biomed Pharmacother, 2023,161:114507.DOI:10.1016/j.biopha.2023.114507. Cited in this article [1]

[56]	Xavier AC, Suzuki R, Attarbaschi A. Diagnosis and management of rare paediatric Non-Hodgkin lymphoma[J]. Best Pract Res Clin Haematol, 2023, 36(1):101440.DOI:10.1016/j.beha.2023.101440. Cited in this article [1]

[57]	Gupta SK, Singh P, Chhabra R, et al. Novel pharmacological approach for the prevention of multidrug resistance(MDR)in a human leukemia cell line[J]. Leuk Res, 2021,109:106641.DOI:10.1016/j.leukres.2021.106641. Cited in this article [1]

[58]	Nagappa LB, Thundakattil AV. Co-relation of P-glycoprotein and plasma imatinib in imatinib responders and non-responders patients with chronic myeloid leukaemia[J]. Int J App Pharm, 2023, 15(6):373-378.DOI:10.22159/ijap.2023v15i6.48819. Cited in this article [1]

[59]	Saito T, Zhang ZJ, Tokuriki M, et al. Expression of multidrug resistance protein 1(MRP1)in the rat cochlea with special reference to the blood-inner ear barrier[J]. Brain Res, 2001, 895(1-2):253-257.DOI:10.1016/s0006-8993(01)02020-0. Cited in this article [1]